Author:
Sivakumar Beena,Bhargava Darpan
Reference13 articles.
1. Laskin DM, et al. Temporomandibular disorders: an evidence-based approach to diagnosis and treatment. 1st ed. Chicago, IL: Quintessence Publishing Co Inc.; 2006. p. 343–62.
2. Bouloux GF. The use of synovial fluid analysis for diagnosis of temporomandibular joint disorders. Oral Maxillofac Surg Clin N Am. 2018;30(3):251–6. https://doi.org/10.1016/j.coms.2018.03.001.
3. Aghabeigi B, et al. Temporomandibular joint synovial fluid analysis. Br J Oral Maxillofac Surg. 1993;31:15–20.
4. Fang PK, Ma XC, Ma DL, et al. Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-beta1 in synovial fluid aspirates of patients with temporomandibular disorders. J Oral Maxillofac Surg. 1999;57:922–8. [discussion: 928–9]
5. Fu K, Ma X, Zhang Z, et al. Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain. 1995;9:131–7.